Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival

The CRP level after CN can be a predictive factor for OS in patients with mRCC treated with tyrosine kinase inhibitor.